| Metabasis Therapeutics, Inc. Patent applications |
| Patent application number | Title | Published |
|---|
| 20120093729 | NOVEL PHOSPHORUS-CONTAINING PRODRUGS - Novel cyclic phosphoramidate prodrugs of drugs of formula I | 04-19-2012 |
| 20120046364 | Novel Sulfonic Acid-Containing Thyromimetics, and Methods for Their Use - The present invention relates to sulfonic acid containing compounds of formula IB, in which G, R | 02-23-2012 |
| 20120039845 | NUCLEOSIDE PRODRUGS AND USES THEREOF - Compounds having the formula I or II, wherein R | 02-16-2012 |
| 20110294758 | NOVEL ACTIVATORS OF GLUCOKINASE - The present invention provides for novel compounds of Formulas I and II and pharmaceutically acceptable salts and co-crystals thereof which have glucokinsae activator activity. The present invention further provides for pharmaceutical compositions comprising the same as well as methods of treating, preventing, delaying the time to onset or reducing the risk for the development or progression of a disease or condition for which one or more glucokinase activator is indicated, including Type 1 and 2 diabetes, impaired glucose tolerance, insulin resistance and hyperglycemia. The present invention also provides for processes of making the compounds of Formulas I and II, including salts and co-crystals thereof, and pharmaceutical compositions comprising the same. | 12-01-2011 |
| 20110009356 | NOVEL PHOSPHORUS-CONTAINING PRODRUGS - Novel cyclic phosphoramidate prodrugs of drugs of formula I | 01-13-2011 |
| 20100081634 | Novel Phosphorus-Containing Thyromimetics - The present invention relates to compounds of phosphonic acid-containing T3 mimetics and monoesters thereof, stereoisomers, pharmaceutically acceptable salts, co-crystals, and prodrugs thereof and pharmaceutically acceptable salts and co-crystals of the prodrugs, as well as their preparation and uses for preventing and/or treating metabolic diseases such as obesity, NASH, hypercholesterolemia and hyperlipidemia, as well as associated conditions such as atherosclerosis, coronary heart disease, impaired glucose tolerance, metabolic syndrome x and diabetes. | 04-01-2010 |
| 20090232879 | Thyromimetics for the Treatment of Fatty Liver Diseases - The present invention is directed toward the use of thyromimetic compounds that are thyroid receptor ligands, pharmaceutically acceptable salts thereof, and to prodrugs of these compounds for preventing, treating, or ameliorating fatty liver diseases such as steatosis, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis. | 09-17-2009 |
| 20090131370 | Novel Nucleoside Derivatives - Compounds of Formulae I-XVI, stereoisomers, and pharmaceutically acceptable salts or prodrugs thereof, their preparation, and their uses for the treatment of viral diseases including hepatitis C viral infection, cancer, diabetes, and other diseases are described: formula (I). | 05-21-2009 |
